Department of Pathology

Anna Vilgelm, MD, PhD

Assistant Professor

Anna Vilgelm, PhD




Email Dr. Vilgelm

Office Location:

496 Biomedical Research Tower

Mailing Address:

496 Biomedical Research Tower
460 W 12th Ave
Columbus, OH 43210


Dr. Anna Vilgelm is a cancer biologist with experience in basic and translational studies. The main focus of Dr. Vilgelm's research is on pre-clinical development of effective strategies for metastatic cancer treatment. Currently, Vilgelm laboratory investigates ways to stimulate anti-tumor immunity by inducing “hot”, immune-cell enriched, tumor micro-environment. Specifically, modulation of molecular mechanisms controlling tumor secretome in explored. In addition Dr. Vilgelm's research team is developing personalized medicine approaches to induce synthetic lethality in tumor cells using rational drug combinations. They utilize a variety of pre-clinical research models including 3D organoid cultures of patient's tumor cells and humanized patient-derived models. Our ultimate goal is to develop new therapeutic approaches to stimulate anti-tumor immunity that prevents tumor relapses resulting in long lasting disease control.


2018-2025 NCI MERIT (R37) award

2017-2020 Breast Cancer Research Foundation award

Academic and Medical Appointments

2019-Present Assistant Professor, Department of Pathology, The Ohio State University Wexner Medical Center

2017-2019 Research Assistant Professor, Department of Pharmacology, Vanderbilt University

2015-2017 Research Assistant Professor, Department of Cancer Biology, Vanderbilt University

Education and Training

2011-2015 Postdoctoral Fellow, Cancer Biology, Vanderbilt University

2006-2011 Ph.D., Molecular Biology, Vanderbilt University and Engelhardt Institute of Molecular Biology

2005 M.D., Medical Biochemistry, Russian National Research Medical University

Selected Publications

Search in PubMed